Literature DB >> 21393508

Structure of an agonist-bound human A2A adenosine receptor.

Fei Xu1, Huixian Wu, Vsevolod Katritch, Gye Won Han, Kenneth A Jacobson, Zhan-Guo Gao, Vadim Cherezov, Raymond C Stevens.   

Abstract

Activation of G protein-coupled receptors upon agonist binding is a critical step in the signaling cascade for this family of cell surface proteins. We report the crystal structure of the A(2A) adenosine receptor (A(2A)AR) bound to an agonist UK-432097 at 2.7 angstrom resolution. Relative to inactive, antagonist-bound A(2A)AR, the agonist-bound structure displays an outward tilt and rotation of the cytoplasmic half of helix VI, a movement of helix V, and an axial shift of helix III, resembling the changes associated with the active-state opsin structure. Additionally, a seesaw movement of helix VII and a shift of extracellular loop 3 are likely specific to A(2A)AR and its ligand. The results define the molecule UK-432097 as a "conformationally selective agonist" capable of receptor stabilization in a specific active-state configuration.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21393508      PMCID: PMC3086811          DOI: 10.1126/science.1202793

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  36 in total

1.  Conformations of the active and inactive states of opsin.

Authors:  R Vogel; F Siebert
Journal:  J Biol Chem       Date:  2001-08-13       Impact factor: 5.157

2.  Mutagenesis reveals structure-activity parallels between human A2A adenosine receptors and biogenic amine G protein-coupled receptors.

Authors:  Q Jiang; B X Lee; M Glashofer; A M van Rhee; K A Jacobson
Journal:  J Med Chem       Date:  1997-08-01       Impact factor: 7.446

3.  Hydrophilic side chains in the third and seventh transmembrane helical domains of human A2A adenosine receptors are required for ligand recognition.

Authors:  Q Jiang; A M Van Rhee; J Kim; S Yehle; J Wess; K A Jacobson
Journal:  Mol Pharmacol       Date:  1996-09       Impact factor: 4.436

Review 4.  International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update.

Authors:  Bertil B Fredholm; Adriaan P IJzerman; Kenneth A Jacobson; Joel Linden; Christa E Müller
Journal:  Pharmacol Rev       Date:  2011-02-08       Impact factor: 25.468

5.  Allosteric modulation of A(2A) adenosine receptors by amiloride analogues and sodium ions.

Authors:  Z G Gao; A P Ijzerman
Journal:  Biochem Pharmacol       Date:  2000-09-01       Impact factor: 5.858

6.  Exploring distal regions of the A3 adenosine receptor binding site: sterically constrained N6-(2-phenylethyl)adenosine derivatives as potent ligands.

Authors:  Susanna Tchilibon; Soo-Kyung Kim; Zhan-Guo Gao; Brian A Harris; Joshua B Blaustein; Ariel S Gross; Heng T Duong; Neli Melman; Kenneth A Jacobson
Journal:  Bioorg Med Chem       Date:  2004-05-01       Impact factor: 3.641

7.  Crystal structure of the human beta2 adrenergic G-protein-coupled receptor.

Authors:  Søren G F Rasmussen; Hee-Jung Choi; Daniel M Rosenbaum; Tong Sun Kobilka; Foon Sun Thian; Patricia C Edwards; Manfred Burghammer; Venkata R P Ratnala; Ruslan Sanishvili; Robert F Fischetti; Gebhard F X Schertler; William I Weis; Brian K Kobilka
Journal:  Nature       Date:  2007-10-21       Impact factor: 49.962

8.  Identification of essential residues involved in the allosteric modulation of the human A(3) adenosine receptor.

Authors:  Zhan-Guo Gao; Soo-Kyung Kim; Ariel S Gross; Aishe Chen; Joshua B Blaustein; Kenneth A Jacobson
Journal:  Mol Pharmacol       Date:  2003-05       Impact factor: 4.436

9.  GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function.

Authors:  Daniel M Rosenbaum; Vadim Cherezov; Michael A Hanson; Søren G F Rasmussen; Foon Sun Thian; Tong Sun Kobilka; Hee-Jung Choi; Xiao-Jie Yao; William I Weis; Raymond C Stevens; Brian K Kobilka
Journal:  Science       Date:  2007-10-25       Impact factor: 47.728

10.  Site-directed mutagenesis identifies residues involved in ligand recognition in the human A2a adenosine receptor.

Authors:  J Kim; J Wess; A M van Rhee; T Schöneberg; K A Jacobson
Journal:  J Biol Chem       Date:  1995-06-09       Impact factor: 5.157

View more
  354 in total

1.  Allosteric modulation of seven transmembrane spanning receptors: theory, practice, and opportunities for central nervous system drug discovery.

Authors:  Bruce J Melancon; Corey R Hopkins; Michael R Wood; Kyle A Emmitte; Colleen M Niswender; Arthur Christopoulos; P Jeffrey Conn; Craig W Lindsley
Journal:  J Med Chem       Date:  2012-01-06       Impact factor: 7.446

2.  Emerging adenosine receptor agonists: an update.

Authors:  Zhan-Guo Gao; Kenneth A Jacobson
Journal:  Expert Opin Emerg Drugs       Date:  2011-12-07       Impact factor: 4.191

3.  Structural aspects of M₃ muscarinic acetylcholine receptor dimer formation and activation.

Authors:  Jianxin Hu; Doreen Thor; Yaru Zhou; Tong Liu; Yan Wang; Sara M McMillin; Rajendra Mistry; R A John Challiss; Stefano Costanzi; Jürgen Wess
Journal:  FASEB J       Date:  2011-10-26       Impact factor: 5.191

4.  Signaling by sensory receptors.

Authors:  David Julius; Jeremy Nathans
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-01-01       Impact factor: 10.005

5.  Frozen out: molecular modeling in the age of cryocrystallography.

Authors:  Yvonne C Martin; Steven W Muchmore
Journal:  J Comput Aided Mol Des       Date:  2011-12-24       Impact factor: 3.686

6.  Differential sensitivity of types 1 and 2 cholecystokinin receptors to membrane cholesterol.

Authors:  Ross M Potter; Kaleeckal G Harikumar; S Vincent Wu; Laurence J Miller
Journal:  J Lipid Res       Date:  2011-10-21       Impact factor: 5.922

7.  Design and in Vivo Characterization of A1 Adenosine Receptor Agonists in the Native Ribose and Conformationally Constrained (N)-Methanocarba Series.

Authors:  Dilip K Tosh; Harsha Rao; Amelia Bitant; Veronica Salmaso; Philip Mannes; David I Lieberman; Kelli L Vaughan; Julie A Mattison; Amy C Rothwell; John A Auchampach; Antonella Ciancetta; Naili Liu; Zhenzhong Cui; Zhan-Guo Gao; Marc L Reitman; Oksana Gavrilova; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2019-01-03       Impact factor: 7.446

8.  Structural Connection between Activation Microswitch and Allosteric Sodium Site in GPCR Signaling.

Authors:  Kate L White; Matthew T Eddy; Zhan-Guo Gao; Gye Won Han; Tiffany Lian; Alexander Deary; Nilkanth Patel; Kenneth A Jacobson; Vsevolod Katritch; Raymond C Stevens
Journal:  Structure       Date:  2018-01-27       Impact factor: 5.006

9.  Tritium-labeled agonists as tools for studying adenosine A2B receptors.

Authors:  Sonja Hinz; Wessam M Alnouri; Ulrich Pleiss; Christa E Müller
Journal:  Purinergic Signal       Date:  2018-05-11       Impact factor: 3.765

10.  The role of a sodium ion binding site in the allosteric modulation of the A(2A) adenosine G protein-coupled receptor.

Authors:  Hugo Gutiérrez-de-Terán; Arnault Massink; David Rodríguez; Wei Liu; Gye Won Han; Jeremiah S Joseph; Ilia Katritch; Laura H Heitman; Lizi Xia; Adriaan P Ijzerman; Vadim Cherezov; Vsevolod Katritch; Raymond C Stevens
Journal:  Structure       Date:  2013-11-07       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.